BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4038621)

  • 1. Chronic phenytoin and the stereotyped motor response induced by 5-methoxy-N,N-dimethyltryptamine in rats.
    Lalonde R; Botez MI
    Brain Res; 1985 Feb; 326(2):388-91. PubMed ID: 4038621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated chlorpromazine administration increases a behavioural response of rats to 5-hydroxytryptamine receptor stimulation.
    Green AR
    Br J Pharmacol; 1977 Feb; 59(2):367-71. PubMed ID: 264797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists.
    Green AR; Hall JE; Rees AR
    Br J Pharmacol; 1981 Jul; 73(3):703-19. PubMed ID: 6166345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of Ca2+ antagonists and hydralazine on central 5-hydroxytryptamine biochemistry and function in rats and mice.
    Green AR; DeSouza RJ; Davies EM; Cross AJ
    Br J Pharmacol; 1990 Jan; 99(1):41-6. PubMed ID: 1691944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonergic involvement in phencyclidine-induced behaviors.
    Nabeshima T; Yamaguchi K; Hiramatsu M; Amano M; Furukawa H; Kameyama T
    Pharmacol Biochem Behav; 1984 Sep; 21(3):401-8. PubMed ID: 6208563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of acute administration of 5-methoxy-N,N-dimethyltryptamine upon the latency and duration of post-decapitation convulsions.
    Archer T; Tandberg B
    Acta Pharmacol Toxicol (Copenh); 1984 Sep; 55(3):224-30. PubMed ID: 6239520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral and electroencephalographic effects of a serotonin receptor agonist (5-methoxy-N,N-dimethyltryptamine) in a feline model of photosensitive epilepsy.
    Wada Y; Hasegawa H; Nakamura M; Yamaguchi N
    Neurosci Lett; 1992 Apr; 138(1):115-8. PubMed ID: 1407649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responses of developing rats to L-tryptophan plus an MAOI-I. Monitoring changes in behaviour, brain 5-HT and tryptophan.
    Atterwill CK; Green AR
    Neuropharmacology; 1980 Apr; 19(4):325-35. PubMed ID: 7383278
    [No Abstract]   [Full Text] [Related]  

  • 9. Roles of dopamine and 5-hydroxytryptamine in stereotyped and non-stereotyped behaviour.
    Dickinson SL; Curzon G
    Neuropharmacology; 1983 Jul; 22(7):805-12. PubMed ID: 6225959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM; Green AR
    Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An in vivo dialysis and behavioural study of the release of 5-HT by p-chloroamphetamine in reserpine-treated rats.
    Adell A; Sarna GS; Hutson PH; Curzon G
    Br J Pharmacol; 1989 May; 97(1):206-12. PubMed ID: 2720308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analgesia induced by brief footshock: blockade by fenfluramine and 5-methoxy-N,N-dimethyltryptamine and prevention of blockade by 5-HT antagonists.
    Hutson PH; Tricklebank MD; Curzon G
    Brain Res; 1983 Nov; 279(1-2):105-10. PubMed ID: 6315164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responses of developing rats to L-tryptophan plus an maoi-II. Effects of repeated electroconvulsive shock.
    Atterwill CK; Green AR
    Neuropharmacology; 1980 Apr; 19(4):337-41. PubMed ID: 7189832
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased behavioural response to 5-methoxy-N,N-dimethyltryptamine but not to RU-24969 after intraventricular 5,7-dihydroxytryptamine administration.
    Nisbet AP; Marsden CA
    Eur J Pharmacol; 1984 Sep; 104(1-2):177-80. PubMed ID: 6499914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of tolerance to repeated administration of 5-methoxy-N,N-dimethyltryptamine in rats.
    Trulson ME; Keltch GF
    Eur J Pharmacol; 1985 Jan; 108(1):33-7. PubMed ID: 3979433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circling produced by serotonin and dopamine agonists in raphe lesioned rats: a serotonin model.
    Slater P
    Pharmacol Biochem Behav; 1980 Dec; 13(6):817-21. PubMed ID: 7193875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioural evidence for a functional interaction between central 5-HT2 and 5-HT1A receptors.
    Backus LI; Sharp T; Grahame-Smith DG
    Br J Pharmacol; 1990 Aug; 100(4):793-9. PubMed ID: 2145051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian variation in the head twitch response produced by 5-methoxy-N1,N1-dimethyltryptamine and p-chloroamphetamine in the mouse.
    Singleton C; Marsden CA
    Psychopharmacology (Berl); 1981; 74(2):173-6. PubMed ID: 6168003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. beta-Adrenoceptor antagonists inhibit the behavioural responses of rats to increased brain 5-hydroxytryptamine.
    Costain DW; Green AR
    Br J Pharmacol; 1978 Oct; 64(2):193-200. PubMed ID: 30503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of selective 5-hydroxytryptamine uptake inhibitors on 5-methoxy-N,N-dimethyltryptamine-induced ejaculation in the rat.
    Rényi L
    Br J Pharmacol; 1986 Apr; 87(4):639-48. PubMed ID: 2939912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.